Clear cell carcinomas of the mullerian system: Does the pathogenesis vary depending on their nuclear grade and their association with endometriosis? An immunohistochemical analysis

Pathology Research International

Volumn 2012, Issue , 2012, Pages

  Alduaij, Ahmad ^a   Hansen, Katrine ^a   Karim, Tahreem A ^a   Zhang, Cunxian ^a   Lomme, Michelle M ^a   Sung, C James ^a   Lawrence, W Dwayne ^a   Quddus, M Ruhul ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84870176713     PISSN: None     EISSN: 2042003X     Source Type: Journal    
DOI: 10.1155/2012/674748     Document Type: Article

References (21)

1. Schiller W., Mesonephroma ovarii. American Journal of Cancer 1939 35 1 21
2. Serov S. F., Scully R. E., Sobin L. H., International histologic classification of tumors. Histologic Classification of Tumors 1973 9 Geneva, Switzerland World Health Organization
3. Van Der Aa M. A., Helmerhorst T. J. M., Siesling S., Riemersma S., Coebergh J. W., Vaginal and (uncommon) cervical cancers in the Netherlands, 1989-2003. International Journal of Gynecological Cancer 2010 20 4 638 645 2-s2.0-77952259546 10.1111/IGC.0b013e3181a44f4
4. Lester F. C., Farmer D. L., Rabban J. T., Chen L. M., Radical trachelectomy for clear cell carcinoma of the cervix in a 6-year old: a case report, review, and description of the surgical technique. Journal of Pediatric Surgery 2010 45 8 E1 E5 2-s2.0-77955886115 10.1016/j.jpedsurg.2010.05.032
5. Zhao C., Wu L. S., Barner R., Pathogenesis of ovarian clear cell adenofibroma, atypical proliferative (borderline) tumor, and carcinoma: clinicopathologic features of tumors with endometriosis or adenofibromatous components support two related pathways of tumor development. Journal of Cancer 2011 2 94 106
6. Kashiyama M., Suzuki A., Ozawa M., Adenocarcinomas arising from uterine adenomyosis. International Journal of Gynecological Pathology 2002 21 239 245
7. Terada T., Clear cell adenocarcinoma of the ovary arising in atypical endometriosis: a report of eight cases. Archives of Gynecology and Obstetrics 2011 285 1 229 233 2-s2.0-79955974167 10.1007/s00404-011-1929-3
8. Veras E., Mao T. L., Ayhan A., Ueda S., Lai H., Hayran M., Shih I. M., Kurman R. J., Cystic and adenofibromatous clear cell carcinomas of the ovary: distinctive tumors that differ in their pathogenesis and behavior: a clinicopathologic analysis of 122 cases. American Journal of Surgical Pathology 2009 33 6 844 853 2-s2.0-67549148930 10.1097/PAS.0b013e31819c4271
9. Carcangiu M. L., Chambers J. T., Early pathologic stage clear cell carcinoma and uterine papillary serous carcinoma of the endometrium: comparison of clinicopathologic features and survival. International Journal of Gynecological Pathology 1995 14 1 30 38 2-s2.0-0028834072
10. Malpica A., Tornos C., Burke T. W., Silva E. G., Low-stage clear-cell carcinoma of the endometrium. American Journal of Surgical Pathology 1995 19 7 769 774 2-s2.0-0029060720
11. Yamamoto S., Tsuda H., Shimazaki H., Takano M., Yoshikawa T., Kuzuya K., Tsuda H., Kurachi H., Kigawa J., Kikuchi Y., Sugiyama T., Matsubara O., Clear cell adenocarcinoma with a component of poorly differentiated histology: a poor prognostic subgroup of ovarian clear cell adenocarcinoma. International Journal of Gynecological Pathology 2011 30 431 441 2-s2.0-79960864804 10.1097/PGP.0b013e3182165eba
12. Reles A., Schmider A., Schönborn I., Press M. F., Friedmann W., Huber-Schumacher S., Strohmeyer T., Lichtenegger W., Immunostaining of p53 protein in ovarian carcinoma: correlation with histopathological data and clinical outcome. Journal of Cancer Research and Clinical Oncology 1996 122 8 489 494 2-s2.0-0030010914 10.1007/BF01187161 (Pubitemid 26248241)
13. Lax S. F., Pizer E. S., Ronnett B. M., Kurman R. J., Clear cell carcinoma of the endometrium is characterized by a distinctive profile of p53, Ki-67, estrogen, and progesterone receptor expression. Human Pathology 1998 29 6 551 558 2-s2.0-0031746796 10.1016/S0046-8177(98)80002-6 (Pubitemid 28272707)
14. An H. J., Logani S., Isacson C., Ellenson L. H., Molecular characterization of uterine clear cell carcinoma. Modern Pathology 2004 17 5 530 537 2-s2.0-3042721642 10.1038/modpathol.3800057 (Pubitemid 38868419)
15. Delair D., Soslow R. A., Endometrial clear cell carcinomas with and without aberrant p53 expression: a study of 16 cases. Modern Pathology 2012 25 supplement 2 265A
16. Fadare O., Parkash V., Dupont W. D., The diagnosis of endometrial carcinoma with clear cells by gynecologic pathologists: an assessment of interobserver variability and associated morphologic features. The American Journal of Surgical Pathology 2012 36 1107 1118
17. Yemelyanova A., Vang R., Kshirsagar M., Lu D., Marks M. A., Shih I. M., Kurman R. J., Immunohistochemical staining patterns of p53 can serve as a surrogate marker for TP53 mutations in ovarian carcinoma: an immunohistochemical and nucleotide sequencing analysis. Modern Pathology 2011 24 1248 1253 2-s2.0-79955553671 10.1038/modpathol.2011.85
18. Quddus M. R., Sung C. J., Zheng W., Lauchlan S. C., p53 immunoreactivity in endometrial metaplasia with dysfunctional uterine bleeding. Histopathology 1999 35 1 44 49 2-s2.0-0032765142 10.1046/j.1365-2559.1999.00684.x (Pubitemid 29325296)
19. Fukunaga M., Nomura K., Ishikawa E., Ushigome S., Ovarian atypical endometriosis: its close association with malignant epithelial tumours. Histopathology 1997 30 3 249 255 2-s2.0-0030963346 (Pubitemid 27148154)
20. Toki T., Fujii S., Silverberg S. G., A clinicopathologic study on the association of endometriosis and carcinoma of the ovary using a scoring system. International Journal of Gynecological Cancer 1996 6 1 68 75 2-s2.0-0029967515 10.1046/j.1525-1438.1996.06010068.x (Pubitemid 26076501)
21. Itamochi H., Kigawa J., Sugiyama T., Kikuchi Y., Suzuki M., Terakawa N., Low proliferation activity may be associated with chemoresistance in clear cell carcinoma of the ovary. Obstetrics and Gynecology 2002 100 2 281 287 2-s2.0-0036338490 10.1016/S0029-7844(02)02040-9 (Pubitemid 34874791)